FDA approves new drug under special pathway for patients receiving hemodialysis - Defencath (taurolidine and heparin)

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-new-drug-under-special-pathway-patients-receiving-hemodialysis?utm_medium=email&utm_source=govdelivery